Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07186933

Driving Pressure During Surgeries With High Risk for Postoperative Pulmonary Complications

The goal of this clinical trial is to compare two different types of perioperative mechanical ventilation (MV), specifically Protective Mechanical Ventilation (PMV) and MV with the lowest possible Driving Pressure (ΔP), in relation to the appearance of postoperative pulmonary complications (PPCs) in adult patients who are operated and have higher risk of PPCs.

The main questions it aims to answer are:

* Is MV with lower ΔP better than conventional PMV in preventing PPCs in patients with higher risk for PPCs? * Does MV with lower ΔP decrease hospital stay, Intensive Care Unit (ICU) need and mortality? * Does MV with lower ΔP suit better than PMV to lung characteristics and needs intraoperatively?

Researchers will compare MV with the lowest possible Driving Pressure (ΔP) to Protective Mechanical Ventilation (PMV) to see if any of this is more protective than the other concerning PPCs.

All participants will receive perioperative MV.

Half of them will receive conventional Protective Mechanical Ventilation (PMV). This will include well known generally protective settings for mechanical ventilation of patients, concerning volumes, pressures, respiratory rate, inspiratory gases and ventilation maneuvers.

The rest of participants will be ventilated with the lowest possible Driving Pressure (ΔP). This will be similar to PMV in the chosen volumes, respiratory rate, inspiratory gases and ventilation maneuvers. However, the pressure inside lung at the end of expiration, eg Positive End Expiratory Pressure (PEEP), will be not be preset for every patient. Initially, the investigators will perform a maneuver that will quantify each individual's lung characteristics and mechanics. According to this, the investigators will find the exact PEEP that seems to suit each patients lungs most, and use this perioperatively, trying to provide lungs the best conditions every time.

After the completion of the operation, all the patients will be screened for PPCs, via arterial blood testing and chest X ray, and the results will be statistically analyzed trying to find if any of the forementioned strategies of mechanical ventilation surpasses the other concerning PPCs appearance. PPCs include atelectasis, respiratory failure, bronchospasm, pleural effusion, pneumonia, aspiration and pneumothorax.

Furthermore hospital stay, ICU need and mortality will be noted. Finally, measurements of perioperative lung pressures, volumes and derived variables will be noted and compared statistically as well.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital of Patras

Pátrai, 26504, Greece

Location status: Recruiting

Location contact

Diamanto Aretha, Associate Professor

CONTACT

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • >17 years old
  • Surgery with general anesthesia & invasive mechanical ventilation
  • Preoperative ARISCAT score estimation >25

Exclusion criteria

  • <18 years old
  • Preoperative ARISCAT score estimation <26
  • Women during pregnancy or just given birth
  • Other type of anesthesia (Not general)
  • Contraindication of administration of neuromuscular blockade agents.
  • Contraindication of cease of spontaneous ventilation.
  • Mechanical ventilation without endotracheal intubation.
  • Severe heart failure / Severe cardiac arrhythmia.
  • Severe emphysematous lung disease.
  • Patient denial of participation in the trial.

Treatment and study plan

PEEP titration for Minimum Driving Pressure

Procedure

This group is mechanically ventilated with Invasive Mechanical Ventilation with Volume Control Ventilation mode with PEEP Initially 8 cm H2O. Afterwards, the lungs are recruited with the aforementioned maneuver. During subsequent derecruitment, PEEP is decreased by 2 cm H20 and compliance is noted in each stage. The goal is to find PEEP with maximum compliance (Cmax). A new recruitment maneuver follows and during derecruitment PEEP is set at the optimum value that was previously defined.

VT 8 ml/kg IBW RR --> PaCO2 = 35-45 mmHg FiO2 0.4 - 0.5 --> SpO2 > 93% Recruitment Maneuver (as described) every hour

Other names: Maximum compliance mechanical ventilation, Cmax Mechanical Ventilation

Lung Protective Ventilation

Procedure

This group is mechanically ventilated with Invasive Mechanical Ventilation with Volume Control Ventilation mode with PEEP 8 cm H2O. VT 8 ml/kg IBW RR --> PaCO2 = 35-45 mmHg FiO2 0.4 - 0.5 --> SpO2 > 93% Recruitment Maneuvers (as described) every hour

Primary outcomes

  1. Postoperative Pulmonary Complications

    Time frame: Atelectasis -> Within 1 hour in PACURespiratory failure -> Immediately postoperatively & after 30 minutes in PACU.Bronchospasm, Pleural Effusion, Pneumonia, Aspiration Pneumonitis, Pneumothorax -> from immediately postoperative until end of study

    Number of the following Postoperative Pulmonary Complications

    • Postoperative Atelectasis (based on Chest X-Ray in Post-Anesthesia Care Unit - PACU)
    • Postoperative Respiratory Failure based on Arterial Blood Gases in PACU (type I and/or II)
    • Postoperative Bronchospasm
    • Postoperative Pleural Effusion
    • Postoperative Pneumonia
    • Postoperative Aspiration Pneumonitis
    • Postoperative Postoperative Pneumothorax

Secondary outcomes

  1. Hospital Stay

    Time frame: From day of operation until the end of patient stay inside hospital, because of return to home or due to death.

    Total hospital stay days from day of operation until hospital discharge.

  2. ICU need.

    Time frame: From day of operation until the end of patient stay inside hospital, because of return to home or due to death.

    Potential Need for ICU admission.

  3. ICU stay

    Time frame: From day of operation until the end of patient stay inside hospital, because of return to home or due to death.

    In case of ICU need, total days of ICU stay.

  4. 28 Day mortality

    Time frame: From day of operation until up to 28 days.

    Incidence of death in 28 days in each group.

  5. Mechanical Power (MP)

    Time frame: From the moment of beginning of operation until the moment of the end of operation and mechanical ventilation

    To calculate MP, the following must be recorded: RR, Peak Airway Pressure (Ppeak), Plateau Pressure (Pplat), and PEEP. The simplified equation will be used; MP = 0.098 × RR × [Ppeak - (Plat-PEEP)/2]

  6. Volume-normalized Mechanical Power (MPcrs)

    Time frame: From the moment of beginning of operation until the moment of the end of operation and mechanical ventilation

    MPcrs = MP/Respiratory System Compliance (Crs)

  7. Elastic Power (EP)

    Time frame: From the moment of beginning of operation until the moment of the end of operation and mechanical ventilation

    To calculate EP, the following must be recorded: RR, VT, Pplat, and PEEP. The following equation will be used: EP = 0.098 × RR × VT × [(Plat+PEEP)/2]

  8. Volume-normalized Elastic Power (EPcrs)

    Time frame: From the moment of beginning of operation until the moment of the end of operation and mechanical ventilation

    EPcrs = EP/Crs

Study contacts

Contact information is provided by the study sponsor or research team.

Antonios D Kostouros, Resident

CONTACT

[email protected]

+306975920528

Sponsors and collaborators

Lead sponsor

University General Hospital of Patras

Other

Registry information

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Sep 22, 2025
Registry last updated
Feb 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.